US FDA warns J&J over Ultram ER web video
This article was originally published in Scrip
Executive Summary
A webcast video for Johnson & Johnson's opioid analgesic Ultram ER (tramadol extended release) minimises the drug's serious risks and overstates its efficacy, the US FDA said in a recent warning letter.